The Story of GLP-1 - Episode 1: "A diabetes doctor’s dream"

Some people eat too much food. Others eat unhealthy food, perhaps because they cannot afford healthy alternatives. Other people continue to eat a balanced diet but still struggle with their weight. How we eat and how our bodies react to food greatly affects our health. More than a third of all deaths today are caused by diseases such as obesity and type 2 diabetes.
But why does the body tell us that it wants more food - even though it has enough energy? And can you get the body to settle for what it needs by adjusting the body’s control systems? These questions have puzzled researchers for decades. And translating new knowledge into something to combat these diseases turned out to be extremely challenging.
In the 1990s, as the obesity pandemic spreads, even young people start to lose their ability to keep their body weight and blood glucose in balance. In turn, researchers and pharmaceutical companies set out to find new remedies.
Follow the Episode 1 "A diabetes doctor’s dream" of this year's Advent Calendar: The Story of GLP-1.

[@user-vb8qw7fn9t]

Brilliant! Huge global impact benefiting millions of people worldwide!

[@crissya.1932]

Thank you, Lotte 🥹❤️🙏🙏🙏

[@bqwriter]

What an inspiring program, beautifully produced and executed!

[@VernCrisler]

I think Lotte and all those involved should receive a Nobel prize in medicine for their development of GLP-1 drugs. As many have said, it's a game changer for diabetes management and obesity management, not to mention possible benefits for heart and neurological health.

[@-.-_123]

I'm very thankful for this work. It is really helping me overcome diabetes and I feel great! Much appreciated!❤

[@xrang1]

Jens Juul Holst is affiliated with the "Department of Biomedical Sciences" and not "biomechanical sciences". That would be an entirely different branch of research not relevant to GLP-1.